Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: A large retrospective study
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume 62, Issue 1, Pages 40-44
Publisher
Wiley
Online
2014-09-23
DOI
10.1002/pbc.25230
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Randomised phase II study of axitinib or bevacizumab combined with paclitaxel/carboplatin as first-line therapy for patients with advanced non-small-cell lung cancer
- (2013) C. Twelves et al. ANNALS OF ONCOLOGY
- Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401
- (2013) Koichi Takayama et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma
- (2013) Anna Raciborska et al. PEDIATRIC BLOOD & CANCER
- A Modified Protocol with Vincristine, Topotecan, and Cyclophosphamide for Recurrent/Progressive Ewing Sarcoma Family Tumors
- (2013) Rejin Kebudi et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Carboplatin plus etoposide for extensive stage small-cell lung cancer: An experience with AUC 6 doses of carboplatin
- (2012) U Yilmaz et al. INDIAN JOURNAL OF CANCER
- Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer
- (2012) Luhua Wang et al. LUNG CANCER
- Phase II Study of Sequential Gemcitabine Followed by Docetaxel for Recurrent Ewing Sarcoma, Osteosarcoma, or Unresectable or Locally Recurrent Chondrosarcoma: Results of Sarcoma Alliance for Research Through Collaboration Study 003
- (2012) E. Fox et al. ONCOLOGIST
- Gemcitabine and docetaxel (GEMDOX) for the treatment of relapsed and refractory pediatric sarcomas
- (2012) Louis Rapkin et al. PEDIATRIC BLOOD & CANCER
- Risk of recurrence and survival after relapse in patients with Ewing sarcoma
- (2011) Martin Stahl et al. PEDIATRIC BLOOD & CANCER
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
- (2009) Linda Granowetter et al. JOURNAL OF CLINICAL ONCOLOGY
- Treatment of Relapsed/Refractory Pediatric Sarcomas With Gemcitabine and Docetaxel
- (2009) Jaume Mora et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma
- (2009) S. Ferrari et al. PEDIATRIC BLOOD & CANCER
- Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma
- (2008) Fariba Navid et al. CANCER
- EWS/FLI Mediates Transcriptional Repression via NKX2.2 during Oncogenic Transformation in Ewing's Sarcoma
- (2008) Leah A. Owen et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started